COM:ONEMEDNET
OneMedNet
- Stock
Last Close
0.84
22/11 21:00
Market Cap
26.00M
Beta: -
Volume Today
60.97K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | |||||
average payables | 3.50M - | ||||
average receivables | 143.55K - | 505.43K 252.09% | 535.38K 5.93% | ||
book value per share | -0.59 - | -1.18 99.42% | -2.20 87.10% | ||
capex per share | -0.01 - | -0.01 94.20% | |||
capex to depreciation | -2.07 - | -2.34 13.25% | -1.56 33.28% | ||
capex to operating cash flow | 0.02 - | 0.01 39.40% | -0.01 154.11% | ||
capex to revenue | -0.03 - | -0.05 83.93% | -0.04 15.08% | ||
cash per share | 0.02 - | 0.14 783.17% | 0.06 61.27% | ||
days of inventory on hand | |||||
days payables outstanding | 1.33K - | ||||
days sales outstanding | 86.54 - | 30.67 64.56% | 291.03 848.88% | 54.18 81.38% | |
debt to assets | 7.92 - | 5.55 29.98% | 7.30 31.69% | 11.02 50.86% | |
debt to equity | -0.91 - | -0.86 5.44% | -0.94 9.52% | -0.40 57.82% | |
dividend yield | |||||
earnings yield | -0.06 - | -0.06 2.16% | -0.13 116.01% | ||
enterprise value | 50.42M - | 53.07M 5.25% | 60.28M 13.59% | 5.05M 91.62% | |
enterprise value over ebitda | -17.28 - | -19.43 12.46% | -9.82 49.46% | -0.42 95.70% | |
ev to operating cash flow | -23.73 - | -28.77 21.27% | -10.20 64.56% | 0.61 106.03% | |
ev to sales | 61.19 - | 48.61 20.56% | 52.29 7.58% | 4.95 90.54% | |
free cash flow per share | -0.44 - | -0.39 11.80% | -1.23 218.45% | ||
free cash flow yield | -0.04 - | -0.04 13.54% | -0.12 208.08% | ||
graham net net | -0.61 - | -1.20 96.42% | -2.29 90.51% | ||
graham number | 2.78 - | 4.01 44.17% | 8.21 104.39% | ||
income quality | 0.75 - | 0.63 16.73% | 0.90 43.53% | -0.35 139.36% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -13.87 - | -15.28 10.12% | -11.18 26.83% | ||
interest debt per share | 0.54 - | 1.05 96.09% | 2.16 104.97% | ||
inventory turnover | |||||
invested capital | -0.91 - | -0.86 5.44% | -0.94 9.52% | -0.40 57.82% | |
market cap | 47.90M - | 48.87M 2.02% | 50.52M 3.37% | ||
net current asset value | -2.89M - | -5.75M 98.78% | -10.75M 86.92% | -12.96M 20.52% | |
net debt to ebitda | -0.86 - | -1.54 78.15% | -1.59 3.49% | -0.42 73.45% | |
net income per share | -0.58 - | -0.61 4.23% | -1.36 123.28% | ||
operating cash flow per share | -0.44 - | -0.38 13.21% | -1.22 220.47% | ||
payables turnover | 0.27 - | ||||
receivables turnover | 4.22 - | 11.90 182.14% | 1.25 89.46% | 6.74 437.20% | |
research and ddevelopement to revenue | 0.37 - | 0.59 57.88% | 0.83 40.38% | 1.60 93.24% | |
return on tangible assets | -8.60 - | -3.33 61.30% | -4.78 43.50% | -50.11 948.65% | |
revenue per share | 0.17 - | 0.23 32.49% | 0.24 5.58% | ||
roe | 0.99 - | 0.52 47.73% | 0.62 19.34% | 1.80 193.21% | |
roic | 10.39 - | 3.55 65.86% | 10.23 188.25% | 0.95 90.75% | |
sales general and administrative to revenue | 2.51 - | 1.10 56.24% | 2.99 172.75% | 5.16 72.65% | |
shareholders equity per share | -0.59 - | -1.18 99.42% | -2.20 87.10% | ||
stock based compensation to revenue | 0.74 - | 0.09 87.82% | 1.39 1,447.95% | ||
tangible asset value | -2.86M - | -5.70M 99.42% | -10.67M 87.10% | -12.86M 20.53% | |
tangible book value per share | -0.59 - | -1.18 99.42% | -2.20 87.10% | ||
working capital | -1.25M - | -3.92M 212.46% | -8.52M 117.40% | -12.47M 46.39% |
All numbers in USD (except ratios and percentages)